AMPHASTAR PHARMACEUTICALS IN (AMPH) Stock Fundamental Analysis
NASDAQ:AMPH - Nasdaq - US03209R1032 - Common Stock - Currency: USD
We assign a fundamental rating of 7 out of 10 to AMPH. AMPH was compared to 195 industry peers in the Pharmaceuticals industry. AMPH scores excellent on profitability, but there are some minor concerns on its financial health. AMPH is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make AMPH a good candidate for value investing.
1. Profitability
1.1 Basic Checks
AMPH had positive earnings in the past year.
AMPH had a positive operating cash flow in the past year.
In the past 5 years AMPH has always been profitable.
In the past 5 years AMPH always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of AMPH (10.21%) is better than 93.55% of its industry peers.
The Return On Equity of AMPH (21.67%) is better than 94.09% of its industry peers.
With an excellent Return On Invested Capital value of 12.46%, AMPH belongs to the best of the industry, outperforming 90.86% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AMPH is significantly below the industry average of 43.99%.
The last Return On Invested Capital (12.46%) for AMPH is above the 3 year average (11.94%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.21% | ||
| ROE | 21.67% | ||
| ROIC | 12.46% |
ROA(3y)10.22%
ROA(5y)7.84%
ROE(3y)17.58%
ROE(5y)13.18%
ROIC(3y)11.94%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 21.80%, AMPH belongs to the top of the industry, outperforming 94.09% of the companies in the same industry.
AMPH's Profit Margin has improved in the last couple of years.
AMPH's Operating Margin of 29.61% is amongst the best of the industry. AMPH outperforms 93.55% of its industry peers.
In the last couple of years the Operating Margin of AMPH has grown nicely.
AMPH has a better Gross Margin (52.98%) than 61.83% of its industry peers.
In the last couple of years the Gross Margin of AMPH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.61% | ||
| PM (TTM) | 21.8% | ||
| GM | 52.98% |
OM growth 3Y114.39%
OM growth 5YN/A
PM growth 3Y276.41%
PM growth 5YN/A
GM growth 3Y10.26%
GM growth 5Y8.62%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AMPH is still creating some value.
The number of shares outstanding for AMPH remains at a similar level compared to 1 year ago.
Compared to 5 years ago, AMPH has more shares outstanding
Compared to 1 year ago, AMPH has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.00 indicates that AMPH is not in any danger for bankruptcy at the moment.
AMPH has a Altman-Z score of 3.00. This is in the better half of the industry: AMPH outperforms 72.58% of its industry peers.
AMPH has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as AMPH would need 3.51 years to pay back of all of its debts.
The Debt to FCF ratio of AMPH (3.51) is better than 89.78% of its industry peers.
AMPH has a Debt/Equity ratio of 0.82. This is a neutral value indicating AMPH is somewhat dependend on debt financing.
AMPH's Debt to Equity ratio of 0.82 is on the low side compared to the rest of the industry. AMPH is outperformed by 70.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 3.51 | ||
| Altman-Z | 3 |
ROIC/WACC1.32
WACC9.46%
2.3 Liquidity
A Current Ratio of 3.43 indicates that AMPH has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.43, AMPH is in line with its industry, outperforming 51.61% of the companies in the same industry.
AMPH has a Quick Ratio of 2.61. This indicates that AMPH is financially healthy and has no problem in meeting its short term obligations.
AMPH has a Quick ratio of 2.61. This is comparable to the rest of the industry: AMPH outperforms 49.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.43 | ||
| Quick Ratio | 2.61 |
3. Growth
3.1 Past
AMPH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.27%, which is quite impressive.
Measured over the past years, AMPH shows a very strong growth in Earnings Per Share. The EPS has been growing by 70.36% on average per year.
AMPH shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.33%.
AMPH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.94% yearly.
EPS 1Y (TTM)21.27%
EPS 3Y72.76%
EPS 5Y70.36%
EPS Q2Q%-16.52%
Revenue 1Y (TTM)20.33%
Revenue growth 3Y22.59%
Revenue growth 5Y16.94%
Sales Q2Q%5.9%
3.2 Future
Based on estimates for the next years, AMPH will show a small growth in Earnings Per Share. The EPS will grow by 6.54% on average per year.
Based on estimates for the next years, AMPH will show a quite strong growth in Revenue. The Revenue will grow by 8.30% on average per year.
EPS Next Y20.24%
EPS Next 2Y14.54%
EPS Next 3Y14.07%
EPS Next 5Y6.54%
Revenue Next Year14.94%
Revenue Next 2Y11.42%
Revenue Next 3Y10.81%
Revenue Next 5Y8.3%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 9.13, the valuation of AMPH can be described as reasonable.
Based on the Price/Earnings ratio, AMPH is valued cheaply inside the industry as 93.55% of the companies are valued more expensively.
AMPH is valuated cheaply when we compare the Price/Earnings ratio to 28.46, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 8.05, which indicates a very decent valuation of AMPH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AMPH indicates a rather cheap valuation: AMPH is cheaper than 90.86% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.56, AMPH is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.13 | ||
| Fwd PE | 8.05 |
4.2 Price Multiples
AMPH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AMPH is cheaper than 90.86% of the companies in the same industry.
91.94% of the companies in the same industry are more expensive than AMPH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.91 | ||
| EV/EBITDA | 7.68 |
4.3 Compensation for Growth
AMPH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AMPH has an outstanding profitability rating, which may justify a higher PE ratio.
AMPH's earnings are expected to grow with 14.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)0.13
EPS Next 2Y14.54%
EPS Next 3Y14.07%
5. Dividend
5.1 Amount
AMPH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMPHASTAR PHARMACEUTICALS IN
NASDAQ:AMPH (1/31/2025, 8:10:46 PM)
After market: 34.9 +0.03 (+0.09%)34.87
-1.5 (-4.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners72.3%
Inst Owner Change3.36%
Ins Owners8.48%
Ins Owner Change-0.54%
Market Cap1.69B
Analysts80
Price Target58.91 (68.94%)
Short Float %12.83%
Short Ratio8.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.21%
Min EPS beat(2)-4.74%
Max EPS beat(2)19.17%
EPS beat(4)2
Avg EPS beat(4)3.54%
Min EPS beat(4)-6.79%
Max EPS beat(4)19.17%
EPS beat(8)6
Avg EPS beat(8)24.28%
EPS beat(12)9
Avg EPS beat(12)20.04%
EPS beat(16)12
Avg EPS beat(16)23.91%
Revenue beat(2)1
Avg Revenue beat(2)0.45%
Min Revenue beat(2)-3.71%
Max Revenue beat(2)4.61%
Revenue beat(4)1
Avg Revenue beat(4)-0.7%
Min Revenue beat(4)-3.71%
Max Revenue beat(4)4.61%
Revenue beat(8)5
Avg Revenue beat(8)1.14%
Revenue beat(12)8
Avg Revenue beat(12)1.24%
Revenue beat(16)11
Avg Revenue beat(16)1.83%
PT rev (1m)0%
PT rev (3m)-6.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.7%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.13 | ||
| Fwd PE | 8.05 | ||
| P/S | 2.33 | ||
| P/FCF | 9.91 | ||
| P/OCF | 8.1 | ||
| P/B | 2.32 | ||
| P/tB | 12.69 | ||
| EV/EBITDA | 7.68 |
EPS(TTM)3.82
EY10.95%
EPS(NY)4.33
Fwd EY12.42%
FCF(TTM)3.52
FCFY10.09%
OCF(TTM)4.31
OCFY12.35%
SpS14.96
BVpS15.04
TBVpS2.75
PEG (NY)0.45
PEG (5Y)0.13
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.21% | ||
| ROE | 21.67% | ||
| ROCE | 15.46% | ||
| ROIC | 12.46% | ||
| ROICexc | 15.2% | ||
| ROICexgc | 31.92% | ||
| OM | 29.61% | ||
| PM (TTM) | 21.8% | ||
| GM | 52.98% | ||
| FCFM | 23.52% |
ROA(3y)10.22%
ROA(5y)7.84%
ROE(3y)17.58%
ROE(5y)13.18%
ROIC(3y)11.94%
ROIC(5y)N/A
ROICexc(3y)15.69%
ROICexc(5y)N/A
ROICexgc(3y)24.29%
ROICexgc(5y)N/A
ROCE(3y)14.81%
ROCE(5y)N/A
ROICexcg growth 3Y153.1%
ROICexcg growth 5YN/A
ROICexc growth 3Y93.82%
ROICexc growth 5YN/A
OM growth 3Y114.39%
OM growth 5YN/A
PM growth 3Y276.41%
PM growth 5YN/A
GM growth 3Y10.26%
GM growth 5Y8.62%
F-Score8
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 3.51 | ||
| Debt/EBITDA | 2.24 | ||
| Cap/Depr | 72.89% | ||
| Cap/Sales | 5.27% | ||
| Interest Coverage | 7.69 | ||
| Cash Conversion | 78.14% | ||
| Profit Quality | 107.89% | ||
| Current Ratio | 3.43 | ||
| Quick Ratio | 2.61 | ||
| Altman-Z | 3 |
F-Score8
WACC9.46%
ROIC/WACC1.32
Cap/Depr(3y)104.15%
Cap/Depr(5y)139.84%
Cap/Sales(3y)5.67%
Cap/Sales(5y)7.92%
Profit Quality(3y)96.84%
Profit Quality(5y)392.61%
High Growth Momentum
Growth
EPS 1Y (TTM)21.27%
EPS 3Y72.76%
EPS 5Y70.36%
EPS Q2Q%-16.52%
EPS Next Y20.24%
EPS Next 2Y14.54%
EPS Next 3Y14.07%
EPS Next 5Y6.54%
Revenue 1Y (TTM)20.33%
Revenue growth 3Y22.59%
Revenue growth 5Y16.94%
Sales Q2Q%5.9%
Revenue Next Year14.94%
Revenue Next 2Y11.42%
Revenue Next 3Y10.81%
Revenue Next 5Y8.3%
EBIT growth 1Y18.5%
EBIT growth 3Y162.82%
EBIT growth 5YN/A
EBIT Next Year29.12%
EBIT Next 3Y18.28%
EBIT Next 5Y22.62%
FCF growth 1Y89.5%
FCF growth 3Y83.79%
FCF growth 5YN/A
OCF growth 1Y82.05%
OCF growth 3Y47.43%
OCF growth 5Y36.88%